Press Releases

Date	Title	PDF Version
May 05, 2020	Alexion to Acquire Portola
May 01, 2020	Alexion Receives CHMP Positive Opinion for ULTOMIRIS® (ravulizumab) in Atypical Hemolytic Uremic Syndrome (aHUS)
Apr 20, 2020	Alexion Announces Plans to Initiate Phase 3 Study of ULTOMIRIS® (ravulizumab-cwvz) in Hospitalized Patients with Severe COVID-19
Apr 09, 2020	Alexion to Report First Quarter Results and Provide Update on COVID-19 on Wednesday, May 6th, 2020
Apr 01, 2020	Alexion Makes Donations to Support Community Responses to COVID-19 Outbreak
Mar 24, 2020	Alexion Statement on SOLIRIS® (eculizumab) and COVID-19
Mar 05, 2020	Alexion Announces Upcoming Data Presentations at 72nd Annual Meeting of the American Academy of Neurology
Feb 27, 2020	Alexion Announces Launch of Alexion Charitable Foundation and Calls for Grantees
Feb 26, 2020	Alexion to Present at the 40th Annual Cowen Health Care Conference
Feb 20, 2020	Alexion to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Search